FDA Approved: AMVUTTRA — Supplemental Application (Alnylam Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Amvuttra (vutrisiran) submitted by Alnylam Pharmaceuticals, reflecting a regulatory update to its labeling follo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Transthyretin-mediated Amyloidosis with Polyneuropathy

Drugs mentioned

• AMVUTTRA (VUTRISIRAN)

Snippet

SUPPL AP for AMVUTTRA (VUTRISIRAN)